First and second-line therapy of high-risk MDS patients

被引：0
|
作者：
Platzbecker, U. [1 ]
机构：
[1] Uniklin Dresden, Med Klin 1, Dresden, Germany
来源：
ONKOLOGIE | 2013年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [21] The Transition From First-Line to Second-Line Therapy in Multiple Sclerosis
    Doerr, Jan
    Paul, Friedemann
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2015, 17 (06)
  • [22] Fitness Burden for the Stepwise Acquisition of First- and Second-Line Antimicrobial Reduced-Susceptibility in High-Risk ESKAPE MRSA Superbugs
    Chines, Eleonora
    Aluisio, Gaia Vertillo
    Santagati, Maria
    Mezzatesta, Maria Lina
    Cafiso, Viviana
    ANTIBIOTICS-BASEL, 2025, 14 (03):
  • [23] First-and second-line therapy for metastatic urothelial carcinoma of the bladder
    Yafi, F. A.
    North, S.
    Kassouf, W.
    CURRENT ONCOLOGY, 2011, 18 (01) : E25 - E34
  • [24] Fetal tachycardia: A role for amiodarone as first- or second-line therapy?
    Pezard, Philippe Georges
    Boussion, Francoise
    Sentilhes, Loic
    Lepinard, Catherine
    Couvreur, Marie-Helene
    Victor, Jacques
    Geslin, Philippe
    Descamps, Philippe
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2008, 101 (10) : 619 - 627
  • [25] Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia
    Dickinson, Michael
    Cherif, Honar
    Fenaux, Pierre
    Mittelman, Moshe
    Verma, Amit
    Portella, Maria Socorro O.
    Burgess, Paul
    Ramos, Pedro Marques
    Choi, Jeea
    Platzbecker, Uwe
    BLOOD, 2018, 132 (25) : 2629 - 2638
  • [26] Editorial: fenofibrate as second-line therapy in high risk PBC - more answers or more questions?
    Jones, D. E. J.
    Hansen, B. E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (05) : 648 - 649
  • [27] Combination lipid-lowering therapy as first-line strategy in very high-risk patients
    Ray, Kausik K.
    Reeskamp, Laurens F.
    Laufs, Ulrich
    Banach, Maciej
    Mach, Francois
    Tokgozoglu, Lale S.
    Connolly, Derek L.
    Gerrits, Anja J.
    Stroes, Erik S. G.
    Masana, Luis
    Kastelein, John J. P.
    EUROPEAN HEART JOURNAL, 2022, 43 (08) : 830 - 833
  • [28] Letter to the Editor: Second-line cannabis therapy in patients with epilepsy
    Riaz, Minahil
    Anwar, Amna
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 229
  • [29] Pemetrexed in second-line therapy in patients with malignant pleural mesothelioma
    Serke, M.
    Bauer, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] Quality of life features in patients on the second-line antituberculosis therapy
    Pyanzova, T., V
    Luzina, N., V
    BYULLETEN SIBIRSKOY MEDITSINY, 2012, 11 (04): : 163 - 164
12345